1 / 16

Cellulitis

Cellulitis. Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital. Some Facts. Definition – “a diffuse spreading inflammation of the subcutaneous tissue caused by bacterial infection” True incidence not really known Not reportable so no definitive data

ksnyder
Download Presentation

Cellulitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cellulitis Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital

  2. Some Facts • Definition – “a diffuse spreading inflammation of the subcutaneous tissue caused by bacterial infection” • True incidence not really known • Not reportable so no definitive data • SSTI’s account for around 176 admissions per 100,000 of the UK population • Accounted for ~3% of emergency medical consultations in one UK hospital • A 2006 study in the USA found an incidence of 24.6 cases per 1000 person years

  3. Bites / Stings Skin breaks E.g. fissures, cuts, puncture wounds, lacerations Other infections E.g.Athletes foot Diabetes PVD Ischaemic ulcers Obesity Lymphoedema Risk Factors

  4. Clinical Signs and Symptoms • Tenderness and heat • Pain • Erythema • Swelling

  5. Clinical Signs and Symptoms • Tenderness and heat • Pain • Erythema • Swelling • Malaise • Fever / Chills • Poorly demarcated borders • Local abcesses

  6. Complications • Abcess formation • Septicaemia • Lymphoedema • Necrotizing skin infections

  7. Causes • Microbiological diagnosis is rare • Primarily Gram +ve organisms • Group A Streptococcus (also groups B,C and G) • Staphylococcus aureus • Less commonly: • Gram –ve’s such as E.coli, Pseudomonas • Anaerobes - esp secondary to wounds, ulcers, diabetic foot • Some rare other causes

  8. Treatment • Prompt Antibiotics • Severe cases need hospital admission for IV therapy • Non-severe cases can be managed at home with oral antibiotics • Bed rest and elevation of the affected part • Analgesia • Good skin care

  9. Which patients should be admitted to hospital? • Signs of septicaemia (hypotension, tachycardia, severe pyrexia, confusion, tachypnoea or vomiting) • Continuing or deteriorating systemic signs after 48 hours of treatment • Unresolving or deteriorating local signs despite trials of first and second line antibiotics

  10. Antibiotic Therapy • MUST choose a drug which covers Group A Streptococcus and Staph aureus* • Flucloxacillin is the first line choice (good activity against both organisms) • Amoxicillin is highly active against Group A Strep but not against Staph. aureus • Several alternatives in penicillin allergy including Macrolides (erythromycin, clarithromycin), Clindamycin, Cephalosporins (Cefuroxime) and some others *Group A Strep is the most common in Lymphoedema

  11. Antibiotic Therapy (2) • Very occasionally use two agents in combination most usually Benzylpenicillin + Flucloxacillin • In severe case may add another agent such as Gentamicin to give good gram –ve cover • If MRSA is suspected will need an anti-MRSA agent such as Vancomycin or Teicoplanin

  12. Outcomes • Cellulitis usually responds fully to appropriate antibiotics • IV Abx can be switched to PO once a good response occurs • Total course lengths of 7-14 days are usually required • In lymphoedema longer courses may be necessary – the BLS recommend a minimum of 14 days from the time a definite clinical response is observed

  13. Other Considerations • Cellulitis is often recurrent especially in lymphoedema • “in case” antibiotics are recommended for any patient who has had a previous attack • 2 weeks of amoxicillin, flucloxacillin or clindamycin • Prophylactic antibiotics - the jury is undecided! • BLS suggest this should be offered to patients who have two or more attacks per year • Penicillin or erythromycin is appropriate • Initially for 1 – 2 years (lifelong if further episode) • Limited evidence only – a 2014 meta analysis of 5 trials (535 pts) concluded that prophylaxis is effective but much more research is needed

More Related